To homepage
4.6/5
TrustPilot
820К+ patients have got assistance since 2014
50 countries
1,500 clinics
6K+ reviews
3K+ qualified doctors

How Much Does Immunotherapy with Keytruda (Pembolizumab) Cost in Spain?

The cost of immunotherapy with Keytruda (pembrolizumab) in Spain generally runs from $15,000 to $25,000. Pricing depends on factors such as the number of treatment cycles, the patient’s diagnosis, and the hospital’s location. In the United States, the average cost is $21,500 (per NCCN guidelines). This means immunotherapy with Keytruda in Spain is typically about 30% less than in the U.S.

Spanish hospitals usually include the drug itself, oncologist consultations, infusion sessions, and routine monitoring in the price. In the U.S., medication, administration, and follow-up visits are often billed separately. Always confirm what’s included with each clinic or hospital before starting treatment.

Key Benefits

Why choose Spain for immunotherapy with Keytruda (Pembrolizumab)?

  • Accredited clinics: JCI-certified hospitals in Spain ensure high standards of care and patient safety.
  • Latest technologies: The use of modern devices, such as the latest infusion pumps and monitoring systems, ensures precise administration of Keytruda (Pembrolizumab).
  • High success rates: Keytruda has demonstrated an efficacy rate of 45% in treating certain types of cancers. This significantly improves patient outcomes.
  • Expert surgeons: Leading oncologists in Spain, many of whom are board-certified and have extensive experience, have successfully treated numerous cases with Keytruda. Their expertise contributes to its growing reputation.

Access advanced Immunotherapy with Keytruda (Pembolizumab) solutions in trusted clinics from $14,291.

TurkeyAustriaSpain
Immunotherapy with Keytruda (Pembolizumab)from $3,300from $15,000from $15,000
Data verified by Bookimed as of March 2026, based on patient requests and official quotes from 59 clinics worldwide. Median costs are based on real invoices (2025–2026) and updated monthly. Actual prices may vary.

Your Benefits and Guarantees with Bookimed

Transparent Prices & Flexible Installments

No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy with Keytruda (Pembolizumab) upon arrival and use a flexible installment plan if needed.

Verified Clinics & Doctors Only

Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy with Keytruda (Pembolizumab) and have the necessary licenses to serve international patients worldwide.

Free 24/7 Assistance

Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy with Keytruda (Pembolizumab) journey.

Why we?

Your personal Bookimed medical coordinator

  • Supports you at every stage
  • Helps choose the right clinic and doctor
  • Ensures quick and convenient access to information

Immunotherapy with Keytruda (Pembolizumab) Packages in Spain — March 2026

Procedure type
Guidelines of Memorial Sloan Kettering Cancer Center (USA). Keytruda (1 injection, 200 mg)

Centro Médico Teknon

Spain, Barcelona

Joan Carles Galceran

39 years of experience • 1200+ treatments performed

Treatment follows the precise immunotherapy protocols of Memorial Sloan Kettering Cancer Center. Dr. Joan Carles Galceran, who has performed 1,200+ treatments, oversees the therapy after a personalized review by a multidisciplinary tumor board at the JCI-accredited Centro Médico Teknon. The package, costing around $14,291, includes a 200 mg Keytruda injection, an oncology consultation, and blood analysis with cancer markers. Part of the Quirónsalud group, the clinic provides international coordination and translator services.

4.7441 reviews

Discover the Best Immunotherapy with Keytruda (Pembolizumab) Clinics in Spain: 4 Verified Options and Prices

The Bookimed clinic ranking is based on data science algorithms, providing a trusted, transparent, and objective comparison. It takes into account patient demand, review scores (both positive and negative), the frequency of updates to treatment options and prices, response speed, and clinic certifications.
Hospital Quiron Barcelona

Hospital Quiron Barcelona

Spain, Barcelona

Jesus Soberino

18 years of experience
accreditations :
Clinic is certified :
4.46 reviews
diagnostics
PET/CT $1,800.9
Clinic's page
Hospital HM Nou Delfos

Hospital HM Nou Delfos

Spain, Barcelona

Joan Albanell Mestres

37 years of experience
Clinic is certified :
4.65 reviews
Price on request
Clinic's page
GenesisCare Clinics

GenesisCare Clinics

Spain, Madrid
4.01 review
diagnostics
Consultation with a neurosurgeon$232.37 - $580.94
Clinic's page

Immunotherapy with Keytruda (Pembolizumab) Overview in Spain

Takeaways
Related procedures & Costs
How it works
What to expect
Pros & Cons
Benefits
Payment
patients recommend -
85%
Requests processed - 46119
Bookimed fees - $0

Our Doctors

View all Doctors
verified

Francesc Bosch

126 years of experience

Professor Bosch leads global research in Chronic Lymphocytic Leukemia (CLL) and lymphoma treatments, with over 80 active clinical trials.

  • Specializes in lymphomas and CLL at Hospital Quiron Barcelona
  • Published 100+ articles in top journals like NEJM and Nature Medicine
  • Head of Hematology at Vall d'Hebron University Hospital
  • Develops new therapeutic approaches for lymphoproliferative disorders
verified

Lopez Ibor

32 years of experience

Dr. López-Ibor leads the Pediatric Hematology and Oncology Unit at HM Montepríncipe Hospital, specializing in bone, brain tumors, and leukemia.

  • Over _doctor_3339_years_ of pediatric oncology experience
  • Expert in Hematology and Oncology from the University of Maryland
  • Author of numerous national and international scientific publications
  • Provides specialized care for children and adolescents
verified

Jesus Soberino

18 years of experience

Dr. Jesus Soberino is an oncologist at Vall d’Hebron University Hospital and the Vall d’Hebron Institute of Oncology (VHIO). He specializes in breast cancer and melanoma. Dr. Soberino has led many phase 1–3 clinical trials. His work has helped approve important drugs, including CDK4/6 inhibitors for metastatic breast cancer and immunotherapies for melanoma.

His areas of expertise include endocrine therapy, managing hormone resistance, and developing new immunotherapies. Dr. Soberino is known for his patient-centered care. He actively collaborates in research to improve cancer treatment. He is accredited by VHIO and is a key member of the Breast Cancer and Melanoma Units.

verified

Joan Albanell Mestres

37 years of experience

Dr. Joan Albanell Mestres is a leading oncologist who specializes in breast cancer. He earned his MBBS from the University Autónoma de Barcelona in 1989. He leads the breast cancer program at HM Delfos and oversees Oncology services at Clin del Mar in Spain.

Dr. Albanell has published 120 scientific articles, with over 9,000 citations. He directs cancer research at Del Mar. He is also an active member of GEICAM, CIBERONC, AIECA, and SEOM. He regularly contributes to important oncology research.

Video Stories from Bookimed Patients

Amanda
My companion and I were treated with such kindness — I have nothing but admiration for the entire team.
Procedure: Mastectomy
Clinic: Lokman Hekim Istanbul Hospital
Randolph
Stay strong, stay informed, and never underestimate the power of cutting-edge treatments and a solid support system.
Procedure: Radioembolization for liver cancer
Clinic: Confraternitaet Private Hospital
Niculcea
It’s a tough path — but we’re not walking it alone. And that means everything. Thanks to Bookimed again.
Procedure: Lutetium-177 therapy
Clinic: Memorial Şişli Hospital

Share this content

Twitter XLinkedinFacebookWhatsAppEmail
Get link
Updated: 05/27/2022
Authored by
Anna Leonova
Anna Leonova
Head of Content Marketing Team
A certified medical writer with 10+ years of experience, developed Bookimed’s trusted content, backed by a Master’s in Philology and medical expert interviews worldwide.
Anna Leonova Linkedin
Reviewed by Bookimed Medical Advisor
Fahad Mawlood
Medical Editor & Data Scientist
General practitioner. Winner of 4 scientific awards. Served in Western Asia. Former Team Leader of a medical team supporting Arabic-speaking patients. Now responsible for data processing and medical content accuracy.
Fahad Mawlood Linkedin
This page may feature information relating to various medical conditions, treatments, and healthcare services available in different countries. Please be advised that the content is provided for informational purposes only and should not be construed as medical advice or guidance. Please consult with your doctor or a qualified medical professional before starting or changing medical treatment.

Fast Facts about Immunotherapy with Keytruda (Pembolizumab)

Immunotherapy with Keytruda (Pembolizumab)

Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.

Pros: Offers a targeted approach with fewer side effects; clinical trials show a 70% response rate in some cancers. Suitable for varied cancer types due to its immune modulation properties.
Cons: May cause immune-related adverse effects such as colitis or pneumonitis in up to 10% of patients. Limited effectiveness in tumors with low PD-L1 expression.
Effectiveness: 70% response rate in some cancer types.
Duration: Each session lasts about 30 minutes.
Recovery: Not needed.
Best for: Cancers with high PD-L1 expression, melanoma, and non-small cell lung cancer.
Prices: View costs of other techniques

Get a free consultation

Select the best way to contact you